Founder of 5 different companies, including: Kura Oncology, Inc., Avidity Biosciences, Inc. and Ambrx, Inc. Troy E. Wilson is an entrepreneur and businessperson who has been the head of 9 different companies and presently is Non-Executive Chairman at Avidity Biosciences, Inc. (which he founded in 2012), Chairman, President & Chief Executive Officer at Kura Oncology, Inc. (which he founded in 2014), Executive Chairman of Wellspring Biosciences LLC, Executive Chairman for Abintus Bio, Inc. and Managing Member at Araxes Pharma LLC. Dr. Wilson is also on the board of Puma Biotechnology, Inc.
In the past Troy E. Wilson held the position of President of Wildcat Discovery Technologies, Inc. (he founded the company), Chief Business Officer at Ambrx, Inc. (he founded the company in 2003), Founding Partner of Presidio Partners, Chairman, President & Chief Executive Officer for Zeta Acquisition Corp. III, President, Chief Executive Officer & Director at Intellikine LLC (he founded the company in 2007), Chief Executive Officer for Takeda Pharmaceuticals U.S.A., Inc. and Vice President-Business Development of Novartis Institute for Functional Genomics, Inc.
He received a doctorate and an undergraduate degree from the University of California, Berkeley and a graduate degree from New York University.